Bayram Özhan Selected Research

Follicle Stimulating Hormone (Follitropin)

1/2020

A novel compound heterozygous variant in CYP19A1 resulting in aromatase deficiency with normal ovarian tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bayram Özhan Research Topics

Disease

2	Hypothyroidism 09/2017 - 12/2014
2	Insulin Resistance 03/2015 - 01/2013
2	Glucose Intolerance 01/2013 - 03/2012
1	Acute Kidney Injury (Acute Renal Failure) 08/2021
1	Addison Disease (Addison's Disease) 01/2021
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2021
1	Omani type Spondyloepiphyseal dysplasia 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Ovarian Cysts (Ovarian Cyst) 01/2020
1	Virilism (Virilization) 01/2020
1	Pediatric Obesity 12/2017
1	Overweight 12/2017
1	Wolcott-Rallison syndrome 12/2014
1	Obesity 01/2013

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 01/2013
1	Diphosphonates (Bisphosphonates)IBA 08/2021
1	FludrocortisoneIBA 01/2021
1	SaltsIBA 01/2021
1	Aromatase deficiencyIBA 01/2020
1	GonadotropinsIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2020
1	Nonsense Codon (Nonsense Mutation)IBA 01/2020
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	beta Subunit Thyrotropin (Thyrotropin-beta)IBA 09/2017
1	Thyroid HormonesIBA 12/2014
1	LipidsIBA 01/2013
1	chitotriosidaseIBA 03/2012